Donate
Join Us

Gail Mandel, PhD

Gail Mandel, PhD
November 29, 2022
Leading the Cure for Rett: In Gene Replacement, There’s No Replacement for RSRT
Gail Mandel, PhD
August 25, 2022
RNA Editing and Its Potential to Improve Rett Syndrome Symptoms
Gail Mandel, PhD, and John Sinnamon, PhD
August 10, 2022
Rett Symptoms in Mice Alleviated with RNA Editing
Gail Mandel, PhD
May 26, 2021
Seven New RSRT-Supported Therapeutics Make Their Way Towards Clinical Trials
Gail Mandel, PhD
April 17, 2020
The Power of Three
Gail Mandel, PhD
February 25, 2020
The Launch of a New Partnership
Gail Mandel, PhD
December 13, 2018
World-Class Team Takes on Next Gen Gene Therapy
Gail Mandel, PhD
June 6, 2018
Meeting of the Minds
Gail Mandel, PhD
November 8, 2017
Breakthrough Discoveries for DNA & RNA Editing
Gail Mandel, PhD
October 26, 2017
Editing Out Rett Mutations
Gail Mandel, PhD
March 17, 2017
RSRT Awards $7.5 Million to Research in 2016
Gail Mandel, PhD
December 23, 2015
MECP2 Consortium Progress Report
Gail Mandel, PhD
September 23, 2015
Latest MECP2 News from the Mandel Lab
Gail Mandel, PhD
January 14, 2015
MECP2 Consortium Update – Breaking Down the Walls
Gail Mandel, PhD
January 27, 2014
RSRT Launches the MECP2 Gene Therapy Consortium with a $1.5 Million Investment
Gail Mandel, PhD
January 27, 2014
Shaking World Views
Gail Mandel, PhD
January 3, 2014
Two RSRT-funded Projects Included in Top Ten Most Notable Papers of 2013
Gail Mandel, PhD
August 20, 2013
RSRT-funded Study Shows Gene Therapy Can Reverse Rett Symptoms in Mice